The store will not work correctly when cookies are disabled.
1-(2,6-dichlorophenyl)-4-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline
ID: ALA1278130
Cas Number: 343372-37-2
PubChem CID: 3848696
Max Phase: Preclinical
Molecular Formula: C16H7Cl2F3N4
Molecular Weight: 383.16
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)c1nc2ccccc2n2c(-c3c(Cl)cccc3Cl)nnc12
Standard InChI: InChI=1S/C16H7Cl2F3N4/c17-8-4-3-5-9(18)12(8)14-23-24-15-13(16(19,20)21)22-10-6-1-2-7-11(10)25(14)15/h1-7H
Standard InChI Key: WTRRGKLODXSCQG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
26.7337 2.0957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7325 1.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4472 0.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4454 2.5084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1607 2.0993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1615 1.2726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5869 2.1062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8711 2.5135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5917 1.2764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8752 0.8650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0448 0.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8664 -0.0321 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2042 0.7218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4913 -0.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6859 -0.3768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1326 -0.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3854 -1.7738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1965 -1.9457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7463 -1.3335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2988 2.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0157 2.1149 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.2938 3.3480 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.8786 3.1099 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.5535 -1.5035 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.4356 0.4093 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
6 10 1 0
11 14 1 0
3 6 2 0
14 15 2 0
9 7 1 0
15 16 1 0
1 2 2 0
16 17 2 0
7 8 2 0
17 18 1 0
8 5 1 0
18 19 2 0
19 14 1 0
9 10 1 0
7 20 1 0
5 4 2 0
20 21 1 0
4 1 1 0
20 22 1 0
20 23 1 0
2 3 1 0
19 24 1 0
5 6 1 0
15 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 383.16 | Molecular Weight (Monoisotopic): 382.0000 | AlogP: 5.27 | #Rotatable Bonds: 1 |
Polar Surface Area: 43.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 0.48 | CX LogP: 4.48 | CX LogD: 4.48 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.45 | Np Likeness Score: -1.48 |
References
1. Carosati E, Sforna G, Pippi M, Marverti G, Ligabue A, Guerrieri D, Piras S, Guaitoli G, Luciani R, Costi MP, Cruciani G.. (2010) Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors., 18 (22): [PMID:20951595] [10.1016/j.bmc.2010.09.065] |
2. PubChem BioAssay data set, |